Medical device manufacturers face mounting pressure to deliver innovative products while reducing costs and improving margins. To meet these challenges, many original equipment manufacturers (OEMs) outsource critical operations such as
Continue Reading Building Strong Medtech Partnerships: Keys to Successful Contract Manufacturing Agreements
After several years of volatility and unfavorable market dynamics, the initial public offering (IPO) market for medical technology companies is beginning to reopen meaningfully. Following the most recent IPO boom
Continue Reading From Innovation to IPO: A Strategic Checklist for Medtech Companies
The healthtech industry is experiencing intense competition as companies race to develop software and artificial intelligence (AI) tools for clinical decision support, medical telemetry, robotic surgery, surgical navigation, medical imaging
Continue Reading Building a Future-Proof IP Strategy for AI in Medtech
Following an extended suspension tied to ongoing security conditions in the region, U.S. consular operations in Israel have resumed after the prior closure of the U.S. Branch Office in Tel
Continue Reading U.S. Consular Operations in Israel Resume
In the life sciences sector, long-term success is dependent on more than innovation alone. To secure funding, enter strategic alliances, and achieve leadership in competitive markets, companies must protect their
Continue Reading Why Patent Portfolios are Crucial for Life Science Innovators
With artificial intelligence tools becoming part of everyday decision-making, for some, chatbots are a first stop for help with answering questions, including questions that feel “legal” in nature. Such questions
Continue Reading Think Before You Chat: Using AI for Legal Questions May Waive Privilege and Create Discovery Risks
As innovations continue to accelerate, the technology landscape in 2026 may reach a turning point, marking a shift from research and development (R&D) to adaptation. This year’s outlook highlights a
Continue Reading Outlook 2026: Emerging Technology
The U.S. Securities and Exchange Commission staff issued a joint statement on Jan. 28, 2026, providing greater clarity on the application of the federal securities laws to the category of
Continue Reading SEC Issues Guidance on Applying Federal Securities Laws to Tokenized Securities
After years of resistance from the United States Patent and Trademark Office (USPTO) toward AI patent applications, the patent outlook for AI-related inventions in 2026 appears to be promising thanks
Continue Reading AI Patent Outlook for 2026
On Dec. 18, 2025, President Donald Trump signed the National Defense Authorization Act for Fiscal Year 2026 (NDAA) into law. The NDAA includes Section 8103, the Holding Foreign Insiders Accountable
Continue Reading Congress Abolishes Certain Exemptions for Foreign Private Issuers; Will Now Require Compliance with Section 16(a) Beneficial Ownership Reporting For Directors and Officers